Engineered HSV vector achieves safe long-term transgene expression in the central nervous system
2017 · Scientific Reports · 50 citations
https://doi.org/10.1038/s41598-017-01635-1
G
Gianluca Verlengia
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
25
Papers
606
Citations
13
h-index
13
i10-index
Gianluca Verlengia is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Virus-based gene therapy research & Herpesvirus Infections and Treatments & RNA Interference and Gene Delivery. The author has an h-index of 13, co-authored 22 publications.
Papers by this author
worksDeletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes
2017 · Molecular Therapy — Methods & Clinical Development · 23 citations
https://doi.org/10.1016/j.omtm.2017.06.001
Evaluation of parameters for efficient purification and long-term storage of herpes simplex virus-based vectors
2022 · Molecular Therapy — Methods & Clinical Development · 7 citations
https://doi.org/10.1016/j.omtm.2022.06.007
Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications
2025 · Gene Therapy · 0 citations
https://doi.org/10.1038/s41434-025-00566-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat